31st July, 2019
Xstrahl has just lauched a new video detailing the journery an average orthovoltage radiotherapy patient will experiance with help from the Cheltenham General Hospital.
Xstrahl to spotlight superficial and orthovoltage radiotherapy solutions for skin cancer and benign conditions at ESTRO 2024
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions at the European Society for Radiotherapy and Oncology (ESTRO) Annual Meeting in Glasgow, UK, May 3-7, 2024, stand # 1070.